Cipla To Recalibrate US Investments

A More Measured Approach To US Generic R&D And Specialty

Trees
Cipla Moderating Investments Across US Gx R&D, Specialty • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business